Petersen K-U
Pharmakologe und Toxikologe, RWTH Aachen.
MMW Fortschr Med. 2011 Dec 15;153 Suppl 4:137-42.
The possibility of liver intoxication at therapeutic doses of paracetamol (maximal dailydose of 4 x 1 g) is supported by retrospective, but not by controlled prospective studies. Intended orsuicidal overdosages are frequently misjudged in retrospektive reports. Malnutrition, ethanol consumption, and drugs inducing hepatic metabolism are no established riskfactors at therapeutic dose levels. Dose adaptation in existing liver disease is recommended for longer-term use.Transient increases in transaminase values (> 3 x upper limits of normal) after regulardoses of paracetamol are not proof of hepatic damage unless associated with corresponding symptoms or laboratory changes indicative of compromised hepatic function (total bilirubin, INR). There is insufficient evidence of liver injury by paracetamol at regular dose levels.
回顾性研究支持治疗剂量对乙酰氨基酚(最大日剂量4×1g)存在肝中毒的可能性,但前瞻性对照研究并不支持这一点。回顾性报告中经常误判有意或自杀性过量服药的情况。在治疗剂量水平,营养不良、饮酒及诱导肝代谢的药物并非已确定的危险因素。长期使用时,建议根据现有肝病情况调整剂量。常规剂量对乙酰氨基酚后转氨酶值短暂升高(>正常上限3倍)并非肝损伤的证据,除非伴有相应症状或提示肝功能受损的实验室改变(总胆红素、国际标准化比值)。目前尚无充分证据表明常规剂量对乙酰氨基酚会导致肝损伤。